Tradestie Institutional Equity Comparison Engine

RSPF vs RSPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RSPH Overall Edge

RSPH Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Invesco S&P 500 Equal Weight Health Care ETF (RSPH) driven by superior Momentum & Technical, Options & Structure. Fundamentally, RSPF trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RSPH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RSPF sits in UNCLASSIFIED (11th %ile IV; Dealer Gamma Walls on Pro) against RSPH sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RSPF N/M vs RSPH N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner RSPH
1Y +12.1% vs +30.6% ยท 52W Pos 87% vs 91%
Options & Structure Winner RSPH
UNCLASSIFIED (11th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
RSPF NYSE Arca
Invesco S&P 500 Equal Weight Financials ETF
Institutional Equity
$84.69
-0.66% 1D
Market Cap N/A
1M Return +5.74%
1Y Return +12.13%
Forward P/E N/M
Unified AI Score
44.4 / 100 HOLD
Tech 42.0 Fund 32.0 Flow 50.0 Mom 21.1
RSPH NYSE Arca
Invesco S&P 500 Equal Weight Health Care ETF
Institutional Equity
$40.85
-0.44% 1D
Market Cap N/A
1M Return +5.31%
1Y Return +30.59%
Forward P/E N/M
Unified AI Score
43.6 / 100 HOLD
Tech 25.0 Fund 34.0 Flow 50.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RSPF +12.13% RSPH +30.59% Spread: +18.46 pp (RSPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RSPF TTM Op. Margin: N/A RSPH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RSPF vs RSPH. Trailing 12-month operating profitability (RSPF N/A vs RSPH N/A) and valuation multiples (RSPF N/M vs RSPH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RSPF (1) vs RSPH (2)
Institutional Metric RSPF RSPH Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 87% ($69โ€“$87) 91% ($30โ€“$42) Stronger Trend RSPH
Beta / 30D Volatility Risk Regime 0.47ฮฒ ยท 21% Vol 0.44ฮฒ ยท 20% Vol Lower Realized Risk RSPH
Unified Institutional Score Composite Signal 44.4 / 100 (HOLD) 43.6 / 100 (HOLD) Higher Composite RSPF

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RSPF vs RSPH Buy Guide
RSPF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live RSPF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RSPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RSPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RSPF nor RSPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.